Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jawahar Mehta to Risk Assessment

This is a "connection" page, showing publications Jawahar Mehta has written about Risk Assessment.

 
Connection Strength
  
 
 
2.797
  
  1. Pant S, Deshmukh A, Mehta JL. Reply: neglecting enterococci may lead to a misinterpretation of the consequences of last changes in endocarditis prophylaxis American Heart Association guidelines. J Am Coll Cardiol. 2015 Nov 10; 66(19):2157.
    View in: PubMed
    Score: 0.377
  2. Pant S, Deshmukh A, Badheka A, Mehta JL. Reply: Hospitalizations for Endocarditis in the United States. J Am Coll Cardiol. 2015 Oct 20; 66(16):1847-1848.
    View in: PubMed
    Score: 0.376
  3. Pant S, Deshmukh A, Mehta JL. Reply: Trends in Infective Endocarditis: Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011: The Devil Is in the Details. J Am Coll Cardiol. 2015 Sep 08; 66(10):1202-3.
    View in: PubMed
    Score: 0.373
  4. Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, Hirsch GA, Mehta JL. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015 May 19; 65(19):2070-6.
    View in: PubMed
    Score: 0.365
  5. Mehta P, Mehta JL. Do we know why deaths from heart disease have declined? Am J Cardiol. 2014 Nov 15; 114(10):1627.
    View in: PubMed
    Score: 0.347
  6. Bansal D, Mehta JL. Current approaches to cardiovascular disease risk assessment. Indian Heart J. 2008 Mar-Apr; 60(2 Suppl B):B19-22.
    View in: PubMed
    Score: 0.221
  7. Eigenbrodt ML, Bursac Z, Rose KM, Couper DJ, Tracy RE, Evans GW, Brancati FL, Mehta JL. Common carotid arterial interadventitial distance (diameter) as an indicator of the damaging effects of age and atherosclerosis, a cross-sectional study of the Atherosclerosis Risk in Community Cohort Limited Access Data (ARICLAD), 1987-89. Cardiovasc Ultrasound. 2006 Jan 03; 4:1.
    View in: PubMed
    Score: 0.191
  8. Salah HM, Mehta JL. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):114-118.
    View in: PubMed
    Score: 0.133
  9. Mehta JL, Sukhija R, Romeo F, Sepulveda JL. Value of CRP in coronary risk determination. Indian Heart J. 2007 Mar-Apr; 59(2):173-7.
    View in: PubMed
    Score: 0.052
  10. Sukhija R, Mehta V, Leonardi M, Mehta JL. Implantable cardioverter defibrillators for prevention of sudden cardiac death. Clin Cardiol. 2007 Jan; 30(1):3-8.
    View in: PubMed
    Score: 0.051
  11. Romeo F, Leo R, Clementi F, Razzini C, Borzi M, Martuscelli E, Pizzuto F, Chiricolo G, Mehta JL. Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol. 2007 Feb 01; 99(3):325-8.
    View in: PubMed
    Score: 0.051
  12. Marwali MR, Mehta JL. COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thromb Haemost. 2006 Oct; 96(4):401-6.
    View in: PubMed
    Score: 0.050
  13. Schr?r K, Mehta P, Mehta JL. Cardiovascular risk of selective cyclooxygenase-2 inhibitors. J Cardiovasc Pharmacol Ther. 2005 Jun; 10(2):95-101.
    View in: PubMed
    Score: 0.046
  14. Chen J, Mehta JL. Role of oxidative stress in coronary heart disease. Indian Heart J. 2004 Mar-Apr; 56(2):163-73.
    View in: PubMed
    Score: 0.042
  15. Fuseini M, Goodwin WJ, Ferris EJ, Mehta JL. Does electron beam computer tomography provide added value in the diagnosis of coronary artery disease? Curr Opin Cardiol. 2003 Sep; 18(5):385-93.
    View in: PubMed
    Score: 0.041
  16. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022 02 05; 21(1):20.
    View in: PubMed
    Score: 0.036
  17. Jain N, Hunt SL, Cui H, Phadnis MA, Mahnken JD, Shireman TI, Dai J, Mehta JL, Rasu RS. Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis. Cardiovasc Drugs Ther. 2019 10; 33(5):511-521.
    View in: PubMed
    Score: 0.031
  18. Eigenbrodt ML, Bursac Z, Tracy RE, Mehta JL, Rose KM, Couper DJ. B-mode ultrasound common carotid artery intima-media thickness and external diameter: cross-sectional and longitudinal associations with carotid atherosclerosis in a large population sample. Cardiovasc Ultrasound. 2008 Mar 05; 6:10.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.